SOTVMA CE Event: A Nonconsensual View of the ACVIM Classification of Mitral Valve Disease AND A Glimpse at Felicyn
Liquid State Brewing Company
620 West Green StreetIthaca, NY 14850-5250
United States
* Registration open until 6/9/26 at 4:00 PM (EDT)
Event Details
Presented by: Mark Rishniw BVSc, MS, PhD, DACVIM
This course examines the limitations of the ACVIM mitral valve staging scheme and explores practical alternatives to support clinical decision-making in canine cardiac care. Participants will also receive an introduction to Felicyn and its emerging role in the management of hypertrophic cardiomyopathy (HCM) in cats.
Learning Objectives:
1. Understand the problems with the ACVIM Mitral valve staging scheme
2. Consider alternatives to the scheme that might help make the decision process more practical
3. Learn a little about Felicyn in the treatment of HCM in cats
Agenda
| June 9 | |
| 5:30 PM - 6:00 PM | Registration |
| 6:00 PM - 8:00 PM | Dinner & Lecture |
For More Information:
Mark graduated from Melbourne University in 1987 and went into practice in Melbourne, Australia. After 4 years in practice, he started, and completed a residency in Internal Medicine at Washington State University. He then completed a residency in cardiology at UC Davis, and was subsequently board certified in both specialties. After a year as registrar at Melbourne University, he joined the cardiology service at Cornell University in 1997. Three years later, he embarked on a PhD, and emerged with diploma in hand 9 years later. During this time, he joined the Veterinary Information Network (VIN), where he currently works as a consultant in cardiology and coordinates clinical research projects. He is also an adjunct professor at Cornell University, assisting with teaching and clinical research.
Mark has co-authored 270 peer-reviewed publications on a variety of topics ranging from statistical analyses of heartworm disease to delusional parasitosis. He has a particular interest in cardiac mensuration, especially of the left atrium and in providing clinicians with clinically useful frameworks for their practice with cardiac cases. Mark regularly speaks at international meetings and has been an invited speaker at several meetings on cardiac issues.